Key Shareholder Information
An overview of the most recent information about MDxHealth can be found in the company’s periodic corporate presentation slides. The latest MDxHealth Corporate Presentation can be downloaded here.
Corporate Governance Charter
MDxHealth attaches great value to corporate governance practices. On September 7, 2011, our board of directors approved the current version of MDxHealth’s Corporate Governance Charter. The Charter has been drafted in accordance with the principles and the provisions of the Belgian Corporate Governance Code 2009 issued on March 12, 2009 by the Corporate Governance Committee.
The full text of MDxHealth’s Corporate Governance Charter can be downloaded here.
As a listed company, MDxHealth must comply with rules governing insider trading. The company's dealing code can be found here.
Articles of Association
The Articles of Association are periodically updated. The latest version (July 4, 2012) can be found here:
Share capital history
The history of the share capital issuance since the inception of the company can be found here:
Transparency Declarations of the largest shareholders
Shareholders holding more than 3% of the company’s outstanding shares have provided the company with the notifications of their shareholding. The most recent notifications are here:
Notification Required by Shareholders holding more than 3% of the Outstanding Shares
Each natural or legal person acquiring or transferring MDxHealth’s shares is required to notify MDxHealth and the Financial Services and Markets Authority (FSMA) each time their shareholding crosses a threshold of three percent (3%) of the total number of outstanding shares (the denominator). Such notification is also required each time, as a result of an acquisition or transfer a threshold of five percent (5%) and a multiple of five percent (5%) is crossed. Complete information regarding this requirement is found in Article 14 of MDxHealth’s articles of association.
The transparency notifications should be reported within 5 business days of crossing the threshold by following the procedures outlined on the FSMA website found here.
|Total statutory capital||EUR 20,351,568.70|
|Total number of voting rights (one voting right per share) in MDxHealth SA (denominator)||25,513,440|
|Potential future voting rights attached to shares represented by 1,432,965 currently outstanding warrants (at July 3, 2012)||EUR 1,246,100|
Annual and Extraordinary Shareholders' Meetings
The annual general shareholders’ meeting is held at the registered office or at the place determined in the notice convening the shareholders’ meeting. The meeting is held every year on the last Friday of May at 10 a.m. The notice and agenda, as well as a model of power of attorney are made available here at least 30 calendar days prior to the annual shareholders' meeting.
Next Shareholder's Meeting Material
- Notice/invitation/agenda for the Annual and Extraordinary Shareholders' meetings Convening notice English - Convocation Français
- Proxy form for the Annual and Extraordinary Shareholders' meetings Proxy - Procuration
Recent Shareholder's Meetings
Kempen & Co
|Nomura Code Securities||Michael King|
|Petercam||Jan van den Bossche|
Please note that any opinions, estimates or forecasts made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MDxHealth or its management. Requests for copies of analyst reports should be directed at the respective analyst and institution.
The financial service for the shares of the company is provided in Belgium by ING and Fortis Bank. In the Netherlands, the financial service is provided by Fortis Bank. Shareholders should inform themselves about the c osts that other financial intermediaries may charge in connection with paying agency services.